Prof. S. Sami Karti

EDUCATION

2013 Yeditepe University Faculty of Medicine, Department of Internal Medicine, Department of Hematology / Professor Doctor

2004 KTU Faculty of Medicine, Department of Internal Medicine, Department of Hematology / Faculty Member Associate Professor

2004 KTU Faculty of Medicine, Department of Internal Medicine, Department of Hematology, Lecturer / Faculty Member Assistant Professor Doctor

2000 Marmara University Faculty of Medicine Hematology

1998 Marmara University Faculty of Medicine Internal Medicine

1992 Marmara University Faculty of Medicine

EXPERIENCE

2013 Acıbadem Healthcare Group

2004 – 2008 Denizli State Hospital, Hematology Clinic

1998 – 2000 Marmara University Faculty of Medicine, Department of Internal Medicine, Department of Hematology / Research Assistant

1994 – 1998 Marmara University Faculty of Medicine, Department of Internal Medicine / Research Assistant

1992 – 1994 Dicle University Faculty of Medicine, Department of Internal Medicine / Research Assistant

• Bone marrow transplant

• Thalassemia
• Hematological Disorders
• Sickle Cell Disease
• Neuromuscular Disorders
• Multiple Myeloma
• Lymphoma
• Various Autoimmune Diseases
• Acute Lymphocytic Leukemia
• Aplastic Anemia
• Spinal Injury
• Congenital Neutropenia
• Acute Myelogenous Leukemia (AMI)
• Orthopedic Conditions

The disorders of the lymphatic system i.e., lymph nodes, vessels and blood disorders are managed by these doctors. You can be referred to a Hematologist when you are suffering from Multiple Myeloma (bone marrow, lymph nodes, or white blood cells cancer), Lymphoma (cancer of lymph nodes and vessels) and Leukemia (cancer of blood cells) respectively. Also, sickle cell anemia, thalassemia and anemia are the conditions for which hematologist is the right answer.

• Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. 35, 380-8. Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB, Karti SS
• Crimean-Congo hemorrhagic fever in Turkey.Ksiazeg TG. Emerg Infect Dis. 2004 Aug;10(8):1379-84. Karti SS, Odabasi Z, orten V, Yilmaz M, Sonmez M, Caylan R, Akdogan E, Eren N, Koksal I, Ovali E, Erickson BR, Vincent MJ, Nichol ST, Comer JA, Rollin PE,
• Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparinHepato-Gastroenterology. 50, 1864-6 (2003). Karti SS, Ovali E, Ozgur O, Yilmaz M, Sonmez M, Ratip S, Ozdemir F.
• Philedelphia negative, bcr-abl positive Chronic myeloid leukemia associated with pure red cell Aplasia.Journal of Experimental and Clinical Canser Research, 22, 341-342 (2003), Kartı S.S., Yilmaz M., Sönmez M., Akdoğan R., Ersöz Ş., Uçar F., Ovalı E.
• Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera.Hepato-Gastroenterology 50, 512-4 (2003). Kartı SS, Yılmaz M, Kosucu P, Altun E, Kesen J, Arslan M, Özgür O, Ovalı E.
• Blood coagulation and fibrinolytic activity in hypothyroidism.International Journal of Clinical Practice, 57, 78-81 (2003) Erem C., Kavgacı H., Ersöz H.Ö., Hacıhasanoğlu A., Ukinç K., Kartı S.S., Değer O., Telatar M.
• Clinical Microbiological case: chronic disseminated candidiasis unresponsive to treatment.Clinical Microbiology and Infection, 8, 435-436, 442-444 (2002). Ratip S, Odabaşı Z, Kartı SS, Çetiner M, Yeğen C, Çerikçioğlu N, Bayık M, Korten V.
• Noncardiogenic pulmonary edema in the course of verapamil intoxication.Emergency Medicine Journal, 19, 458-459 (2002). Kartı S.S., Ulusoy H, Yandı M, Gündüz A, Koşucu M, Erol K, Ratip S.
• Effect of Interferon ?2a on reutrophil adhesion and phagocytosis in chronic myeloid leukemia and Behçet?s disease.Clin Rheumatol, 21, 211-214 (2002). . Kartı S. S., Ovalı E, Ratip S, Çetiner M, Direskeneli H, Bayık M, Akoğlu T,
• Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.Haematologica, 85, 464-469 (2000). Ovalı E., Ratip S., Kıbaroğlu A., Tekelioğlu Y., Çetiner M., Kartı S.S., Aydın F., Bayık M., Akoğlu T.